Log in

Relevant bibliographies by topics / Neurosin / Journal articles

Journal articles on the topic 'Neurosin'

To see the other types of publications on this topic, follow the link: Neurosin.

Author: Grafiati

Published: 10 June 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Neurosin.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Terayama, Ryuji, Yoshio Bando, Takayuki Takahashi, and Shigetaka Yoshida. "Differential expression of neuropsin and protease M/neurosin in oligodendrocytes after injury to the spinal cord." Glia 48, no. 2 (2004): 91–101. http://dx.doi.org/10.1002/glia.20058.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Tatebe, Harutsugu, Yoshihisa Watanabe, Takashi Kasai, Toshiki Mizuno, Masanori Nakagawa, Masaki Tanaka, and Takahiko Tokuda. "Extracellular neurosin degrades α-synuclein in cultured cells." Neuroscience Research 67, no. 4 (August 2010): 341–46. http://dx.doi.org/10.1016/j.neures.2010.04.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Yoshida, S. "Expression of protease M/neurosin mRNA in oligodendrocytes." Neuroscience Research 38 (2000): S51. http://dx.doi.org/10.1016/s0168-0102(00)81153-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Kasai, Takashi, Takashi Kasai, Takahiko Tokuda, Toshiki Mizuno, Masanori Nakagawa, Yoshihisa Watanabe, Nozomi Yamaguchi, and Fuyuki Kametani. "Neurosin cleaves the NAC region of α-synuclein." Neuroscience Research 58 (January 2007): S234. http://dx.doi.org/10.1016/j.neures.2007.06.547.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Yamanaka, Hiroki, XiaoPing He, Kazumasa Matsumoto, Sadao Shiosaka, and Shigetaka Yoshida. "Protease M/neurosin mRNA is expressed in mature oligodendrocytes." Molecular Brain Research 71, no. 2 (August 1999): 217–24. http://dx.doi.org/10.1016/s0169-328x(99)00187-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Tatebe, Harutsugu, Yoshihisa Watanabe, Takashi Kasai, Takahiko Tokuda, Toshiki Mizuno, Masaki Tanaka, and Masanori Nakagawa. "Analysis of the degradation of α-synuclein by neurosin." Neuroscience Research 65 (January 2009): S246. http://dx.doi.org/10.1016/j.neures.2009.09.1393.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Menendez, Manuel, Ana Suárez, Patricia Castro, Bernardino Blázquez Menes, Marı́a Teresa Calatayud, and Pablo Pérez-Piñera. "P3-086: Plasmatic neurosin as biomarker of Alzheimer's disease." Alzheimer's & Dementia 2 (July 2006): S398. http://dx.doi.org/10.1016/j.jalz.2006.05.1353.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Menendez-Gonzalez, Manuel, Patricia Castro-Santos, Maria Calatayud, Pablo Perez-Piñera, Renee Ribacoba, Marta Martinez-Rivera, Carmen Gutierrez, Alfonso Lopez-Muñiz, and Ana Suarez. "Plasmatic level of neurosin predicts outcome of mild cognitive impairment." International Archives of Medicine 1, no. 1 (2008): 11. http://dx.doi.org/10.1186/1755-7682-1-11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bando, Yoshio, Shinji Ito, Yoshiko Nagai, Ryuji Terayama, Mari Kishibe, Ying-Ping Jiang, Branka Mitrovic, Takayuki Takahashi, and Shigetaka Yoshida. "Implications of protease M/neurosin in myelination during experimental demyelination and remyelination." Neuroscience Letters 405, no. 3 (September 2006): 175–80. http://dx.doi.org/10.1016/j.neulet.2006.06.030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Iwata, A. "Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies." Human Molecular Genetics 12, no. 20 (August 12, 2003): 2625–35. http://dx.doi.org/10.1093/hmg/ddg283.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Menendez-Gonzalez, Manuel, Patricia Castro-Santos, Ana Suarez, María Teresa Calatayud, Pablo Perez-Pinera, Marta Martinez, Renee Ribacoba, and Carmen Gutierrez. "Value of Measuring Plasmatic Levels of Neurosin in the Diagnosis of Alzheimer's Disease." Journal of Alzheimer's Disease 14, no. 1 (May 9, 2008): 59–67. http://dx.doi.org/10.3233/jad-2008-14106.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Kasai, Takashi, Takahiko Tokuda, Nozomi Yamaguchi, Yoshihisa Watanabe, Fuyuki Kametani, Masanori Nakagawa, and Toshiki Mizuno. "Cleavage of normal and pathological forms of α-synuclein by neurosin in vitro." Neuroscience Letters 436, no. 1 (May 2008): 52–56. http://dx.doi.org/10.1016/j.neulet.2008.02.057.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Yamashiro, Kyoko, Nobuo Tsuruoka, Shiho Kodama, Masafumi Tsujimoto, Yoshiro Yamamura, Takaharu Tanaka, Hiroshi Nakazato, and Nozomi Yamaguchi. "Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain." Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1350, no. 1 (January 1997): 11–14. http://dx.doi.org/10.1016/s0167-4781(96)00187-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Diamandis, Eleftherios P., George M. Yousef, Antoninus R. Soosaipillai, Linda Grass, Ashley Porter, Sheila Little, and Georgia Sotiropoulou. "Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications." Clinical Biochemistry 33, no. 5 (July 2000): 369–75. http://dx.doi.org/10.1016/s0009-9120(00)00145-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Diamandis, Eleftherios P., George M. Yousef, Antoninus R. Soosaipillai, and Peter Bunting. "Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma." Clinical Biochemistry 33, no. 7 (October 2000): 579–83. http://dx.doi.org/10.1016/s0009-9120(00)00182-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Yousef, George M., Liu-Ying Luo, Stephen W. Scherer, Georgia Sotiropoulou, and Eleftherios P. Diamandis. "Molecular Characterization of Zyme/Protease M/Neurosin (PRSS9), A Hormonally Regulated Kallikrein-like Serine Protease." Genomics 62, no. 2 (December 1999): 251–59. http://dx.doi.org/10.1006/geno.1999.6012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Okui, Akira, Katsuya Kominami, Hidetoshi Uemura, Shinichi Mitsui, and Nozomi Yamaguchi. "Characterization of a brain-related serine protease, neurosin (human kaillikrein 6), in human cerebrospinal fluid." Neuroreport 12, no. 7 (May 2001): 1345–50. http://dx.doi.org/10.1097/00001756-200105250-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Bluhm, Alexandra, Sarah Schrempel, Stephan von von Hörsten, Anja Schulze, and Steffen Roßner. "Proteolytic α-Synuclein Cleavage in Health and Disease." International Journal of Molecular Sciences 22, no. 11 (May 21, 2021): 5450. http://dx.doi.org/10.3390/ijms22115450.

Full text

Abstract:

In Parkinson’s disease, aggregates of α-synuclein within Lewy bodies and Lewy neurites represent neuropathological hallmarks. However, the cellular and molecular mechanisms triggering oligomeric and fibrillary α-synuclein aggregation are not fully understood. Recent evidence indicates that oxidative stress induced by metal ions and post-translational modifications such as phosphorylation, ubiquitination, nitration, glycation, and SUMOylation affect α-synuclein conformation along with its aggregation propensity and neurotoxic profiles. In addition, proteolytic cleavage of α-synuclein by specific proteases results in the formation of a broad spectrum of fragments with consecutively altered and not fully understood physiological and/or pathological properties. In the present review, we summarize the current knowledge on proteolytical α-synuclein cleavage by neurosin, calpain-1, cathepsin D, and matrix metalloproteinase-3 in health and disease. We also shed light on the contribution of the same enzymes to proteolytical processing of pathogenic proteins in Alzheimer’s disease and report potential cross-disease mechanisms of pathogenic protein aggregation.

APA, Harvard, Vancouver, ISO, and other styles

19

Terayama, Ryuji, Yoshio Bando, Ying-Ping Jiang, Branka Mitrovic, and Shigetaka Yoshida. "Differential expression of protease M/neurosin in oligodendrocytes and their progenitors in an animal model of multiple sclerosis." Neuroscience Letters 382, no. 1-2 (July 2005): 82–87. http://dx.doi.org/10.1016/j.neulet.2005.03.022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Petraki, Constantina D., Vassiliki N. Karavana, Pavlos T. Skoufogiannis, Sheila P. Little, David J. C. Howarth, George M. Yousef, and Eleftherios P. Diamandis. "The Spectrum of Human Kallikrein 6 (Zyme/Protease M/Neurosin) Expression in Human Tissues as Assessed by Immunohistochemistry." Journal of Histochemistry & Cytochemistry 49, no. 11 (November 2001): 1431–41. http://dx.doi.org/10.1177/002215540104901111.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Wennström, Malin, Yulia Surova, Sara Hall, Christer Nilsson, Lennart Minthon, Fredrik Boström, Oskar Hansson, and Henrietta M. Nielsen. "Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy." PLoS ONE 8, no. 1 (January 8, 2013): e53250. http://dx.doi.org/10.1371/journal.pone.0053250.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Ogawa, Kenichi, Tatsuo Yamada, Yasumi Tsujioka, Junichi Taguchi, Mitsuo Takahashi, Yoshio Tsuboi, Yasuhiro Fujino, et al. "Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease." Psychiatry and Clinical Neurosciences 54, no. 4 (August 2000): 419–26. http://dx.doi.org/10.1046/j.1440-1819.2000.00731.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

MITSUI, SHINICHI, AKIRA OKUI, HIDETOSHI UEMURA, TOSHIKI MIZUNO, TATSUO YAMADA, YOSHIO YAMAMURA, and NOZOMI YAMAGUCHI. "Decreased Cerebrospinal Fluid Levels of Neurosin (KLK6), an Aging-Related Protease, as a Possible New Risk Factor for Alzheimer's Disease." Annals of the New York Academy of Sciences 977, no. 1 (November 2002): 216–23. http://dx.doi.org/10.1111/j.1749-6632.2002.tb04818.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Nielsen, Henrietta M., Malin Wennström, Oskar H. Hansson, Elisabet Londos, and Lennart Minthon. "P2-171: Neurosin levels in CSF as potential marker for clinical differentiation between Alzheimer's disease and dementia with Lewy bodies." Alzheimer's & Dementia 6 (July 2010): S363—S364. http://dx.doi.org/10.1016/j.jalz.2010.05.1219.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Nielsen, Henrietta M., Malin Wennström, Oskar H. Hansson, Elisabet Londos, and Lennart Minthon. "F4-02-01: Neurosin Levels in CSF as Potential Marker for Clinical Differentiation Between Alzheimer's Disease and Dementia With Lewy Bodies." Alzheimer's & Dementia 6 (July 2010): e1-e1. http://dx.doi.org/10.1016/j.jalz.2010.08.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Aimes, Ronald, Andries Zijlstra, John Hooper, Steven Ogbourne, Mae-Le Sit, Simone Fuchs, David Gotley, James Quigley, and Toni Antalis. "Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis." Thrombosis and Haemostasis 89, no. 03 (2003): 561–72. http://dx.doi.org/10.1055/s-0037-1613388.

Full text

Abstract:

SummaryMany serine proteases play important regulatory roles in complex biological systems, but only a few have been linked directly with capillary morphogenesis and angiogenesis. Here we provide evidence that serine protease activities, independent of the plasminogen activation cascade, are required for microvascular endothelial cell reorganization and capillary morphogenesis in vitro. A homology cloning approach targeting conserved motifs present in all serine proteases, was used to identify candidate serine proteases involved in these processes, and revealed 5 genes (acrosin, testisin, neurosin, PSP and neurotrypsin), none of which had been associated previously with expression in endothelial cells. A subsequent gene-specific RT-PCR screen for 22 serine proteases confirmed expression of these 5 genes and identified 7 additional serine protease genes expressed by human endothelial cells, urokinase-type plasminogen activator, protein C, TMPRSS2, hepsin, matriptase/ MT-SP1, dipeptidylpeptidase IV, and seprase. Differences in serine protease gene expression between microvascular and human umbilical vein endothelial cells (HUVECs) were identified and several serine protease genes were found to be regulated by the nature of the substratum, ie. artificial basement membrane or fibrillar type I collagen. mRNA transcripts of several serine protease genes were associated with blood vessels in vivo by in situ hybridization of human tissue specimens. These data suggest a potential role for serine proteases, not previously associated with endothelium, in vascular function and angiogenesis.

APA, Harvard, Vancouver, ISO, and other styles

27

Spencer, Brian, Sarah Michael, Jay Shen, Kori Kosberg, Edward Rockenstein, Christina Patrick, Anthony Adame, and Eliezer Masliah. "Lentivirus Mediated Delivery of Neurosin Promotes Clearance of Wild-type α-Synuclein and Reduces the Pathology in an α-Synuclein Model of LBD." Molecular Therapy 21, no. 1 (January 2013): 31–41. http://dx.doi.org/10.1038/mt.2012.66.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Meseguer, Elena, Devy Diallo, Julien Labreuche, Hugo Charles, Sandrine Delbosc, Gabrielle Mangin, Linsay Monteiro Tavares, Giuseppina Caligiuri, Antonino Nicoletti, and Pierre Amarenco. "Osteopontin Predicts Three-Month Outcome in Stroke Patients Treated by Reperfusion Therapies." Journal of Clinical Medicine 9, no. 12 (December 13, 2020): 4028. http://dx.doi.org/10.3390/jcm9124028.

Full text

Abstract:

Establishing a prognosis at hospital admission after stroke is a major challenge. Inflammatory processes, hemostasis, vascular injury, and tissue remodeling are all involved in the early response to stroke. This study analyzes whether 22 selected biomarkers, sampled at admission, predict clinical outcomes in 153 stroke patients treated by thrombolysis and mechanical endovascular treatment (MET). Biomarkers were related to hemostasis (u-plasminogen activator/urokinase (uPA/urokinase), serpin E1/PAI-1, serpin C1/antithrombin-III, kallikrein 6/neurosin, alpha 2-macroglobulin), inflammation[myloperoxidase (MPO), chemokine ligand 2/monocyte chemoattractant protein-1 chemokine (CCL2/MCP-1), adiponectin, resistin, cell-free DNA (cDNA), CD40 Ligand (CD40L)], endothelium activation (Vascular cell adhesion protein 1 (VCAM-1) intercellular adhesion molecule 1 (ICAM-1), platelet endothelial cell adhesion molecule 1 (CD31/PECAM-1)], and tissue remodeling (total cathepsin S, osteopontin, cystatin C, neuropilin-1, matrix metallopeptidase 2 (MMP-2), matrix metallopeptidase 3 (MMP-3), matrix metallopeptidase 9 (MMP-9), matrix metallopeptidase 13 (MMP-13)]. Correlations between their levels and excellent neurological improvement (ENI) at 24 h and good outcomes (mRS 0–2) at three months were tested. Osteopontin and favorable outcomes reached the significance level (p = 0.008); the adjusted OR per SD increase in log-transformed osteopontin was 0.34 (95%CI, 0.18–0.62). The relationship between total cathepsin S and MPO with ENI, was borderline of significance (p = 0.064); the adjusted OR per SD increase in log-transformed of total cathepsin S and MPO was 0.54 (95%CI, 0.35–0.81) and 0.51 (95%CI, 0.32–0.80), respectively. In conclusion, osteopontin levels predicted three-month favorable outcomes, supporting the use of this biomarker as a complement of clinical and radiological parameters for predicting stroke prognosis.

APA, Harvard, Vancouver, ISO, and other styles

29

Heitler, W. J. "Neurosim." Trends in Neurosciences 19, no. 7 (July 1996): 279. http://dx.doi.org/10.1016/s0166-2236(96)20033-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Reid, S. A. "NeuroSIG." Neurosurgery 23, no. 4 (October 1988): 519???24. http://dx.doi.org/10.1097/00006123-198810000-00023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Neve, Michael. "Neurosis." Lancet 363, no. 9415 (April 2004): 1170. http://dx.doi.org/10.1016/s0140-6736(04)15924-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Bailey, Andrew R. "Neurosis." International Journal of Applied Philosophy 11, no. 2 (1997): 51–61. http://dx.doi.org/10.5840/ijap19971128.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Chen, Zu-Lin, Yoshiharu Momota, Keiko Kato, Manabu Taniguchi, Naoko Inoue, Sadao Shiosaka, and Shigetaka Yoshida. "Expression of Neuropsin mRNA in the Mouse Embryo and the Pregnant Uterus." Journal of Histochemistry & Cytochemistry 46, no. 3 (March 1998): 313–20. http://dx.doi.org/10.1177/002215549804600304.

Full text

Abstract:

Neuropsin is a novel serine protease whose mRNA is expressed in the mouse central nervous system. We examined the expression of neuropsin mRNA during embryonic development using Northern and in situ hybridization in non-neural tissues. The pregnant uterus showed strong expression of neuropsin mRNA, whereas the nonpregnant uterus did not express this mRNA. Expression was first detected in the primary decidual zone at 5.5 days post coitum and was maximized at 10 days post coitum, decreasing remarkably thereafter. During mouse organogenesis, neuropsin expression was observed in the developing heart, lung, thymus, pituitary, choroid plexus, and epithelial linings of the skin, oral cavity, tongue, esophagus, and forestomach. In adult mouse organs, neuropsin mRNA was expressed in epithelial tissues covered by keratinocytes with moderate density, whereas low expression was observed in lung, thymus, and spleen. Neuropsin mRNA expression in developing organs and adult keratinocytes suggests that neuropsin is associated with extracellular matrix modifications and cell migrations.

APA, Harvard, Vancouver, ISO, and other styles

34

Ibrahim Mansurova, Sevda. "Children's neuroses and their causes." SCIENTIFIC WORK 61, no. 12 (December 25, 2020): 24–26. http://dx.doi.org/10.36719/2663-4619/61/24-26.

Full text

Abstract:

The article is devoted to the causes of neurosis in children. Some researchers note that the cause of neurosis is due to psychological factors. In their opinion, the cause of neuroses is the negative processes that a person faces throughout life. The article also describes the types of neuroses and their manifestations.Separately, such concepts as: neurasthenia, hysterical neurosis and obsessive-compulsive neurosis were revealed. Кеу words: child, teenager, communication, problem, development

APA, Harvard, Vancouver, ISO, and other styles

35

Stallmach, Robert, and Sergio M. Gloor. "Neurobin/TMPRSS11c, a novel type II transmembrane serine protease that cleaves fibroblast growth factor-2 in vitro." Biochemical Journal 412, no. 1 (April 25, 2008): 81–91. http://dx.doi.org/10.1042/bj20071432.

Full text

Abstract:

TTSPs [type II TMPRSSs (transmembrane serine proteases)] are a growing family of trypsin-like enzymes with, in some cases, restricted tissue distribution. To investigate the expression of TTSPs in the nervous system, we performed a PCR-based screening approach with P10 (postnatal day 10) mouse spinal cord mRNA. We detected the expression of five known TTSPs and identified a novel TTSP, which we designated neurobin. Neurobin consists of 431 amino acids. In the extracellular part, neurobin contains a single SEA (sea-urchin sperm protein, enterokinase and agrin) domain and a C-terminal serine protease domain. RT–PCR (reverse transcription–PCR) analysis indicated the expression of neurobin in spinal cord and cerebellum. Histochemical analysis of brain sections revealed distinct staining of Purkinje neurons of the cerebellum. Transiently overexpressed neurobin was autocatalytically processed and inserted into the plasma membrane. Autocatalytic activation could be suppressed by mutating Ser381 in the catalytic pocket to an alanine residue. The protease domain of neurobin, produced in Escherichia coli and refolded from inclusion bodies, cleaved chromogenic peptides with an arginine residue in position P1. Serine protease inhibitors effectively suppressed the proteolytic activity of recombinant neurobin. Ca2+ or Na+ ions did not significantly modulate the catalytic activity of the protease. Recombinant neurobin processed 17-kDa FGF-2 (fibroblast growth factor-2) at several P1 lysine and arginine positions to distinct fragments, in a heparin-inhibitable manner, but did not cleave FGF-7, laminin or fibronectin. These results indicate that neurobin is an authentic TTSP with trypsin-like activity and is able to process FGF-2 in vitro.

APA, Harvard, Vancouver, ISO, and other styles

36

Ellard, John. "Compensation neurosis." Medical Journal of Australia 142, no. 10 (May 1985): 535. http://dx.doi.org/10.5694/j.1326-5377.1985.tb113482.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Jackson, P. R. "Compensation neurosis." Medical Journal of Australia 143, no. 4 (August 1985): 176. http://dx.doi.org/10.5694/j.1326-5377.1985.tb122902.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

McMurdo, Rob. "Compensation neurosis." Medical Journal of Australia 143, no. 7 (September 1985): 324. http://dx.doi.org/10.5694/j.1326-5377.1985.tb123047.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Tyrer, Peter. "NEUROSIS DIVISIBLE?" Lancet 325, no. 8430 (March 1985): 685–88. http://dx.doi.org/10.1016/s0140-6736(85)91340-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

ANDERSEN, W. THUNE. "Neurosis cordis1." Acta Medica Scandinavica 112, no. 3-4 (April 24, 2009): 328–37. http://dx.doi.org/10.1111/j.0954-6820.1942.tb13098.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Sashidharan, S. P., P. G. Surtees, J. G. Ingham, P. Mcc Miller, and N. Kreitman. "NEUROSIS DIVISIBLE?" Lancet 325, no. 8439 (May 1985): 1210. http://dx.doi.org/10.1016/s0140-6736(85)92881-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Carson, Robert C. "Neurosis Lives!" Contemporary Psychology: A Journal of Reviews 31, no. 7 (July 1986): 507–8. http://dx.doi.org/10.1037/024880.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Bronisch, T., H. U. Wittchen, C. Krieg, H. U. Rupp, and D. von Zerssen. "Depressive neurosis." Acta Psychiatrica Scandinavica 71, no. 3 (March 1985): 237–48. http://dx.doi.org/10.1111/j.1600-0447.1985.tb01280.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Chadda, R. K., and N. Ahuja. "Dhat Syndrome." British Journal of Psychiatry 156, no. 4 (April 1990): 577–79. http://dx.doi.org/10.1192/bjp.156.4.577.

Full text

Abstract:

Dhat syndrome is a culture-bound sex neurosis of the Indian subcontinent. Fifty-two patients with a presenting complaint of passage of ‘Dhat’ in urine were studied. Diagnosis of neurotic depression, anxiety neurosis, hypochondriacal neurosis, and psychogenic impotence were made in 21, 19, 3, and 1 cases respectively. Seven patients received the diagnosis of pure Dhat syndrome, and one of gonorrhoea.

APA, Harvard, Vancouver, ISO, and other styles

45

García-Alandete, Joaquín. "Rudolf Allers’ conception of neurosis as a metaphysical conflict." History of Psychiatry 31, no. 1 (September 23, 2019): 21–36. http://dx.doi.org/10.1177/0957154x19877295.

Full text

Abstract:

The Viennese psychiatrist and philosopher Rudolf Allers (1883–1963) made important contributions to psychiatry and psychotherapy, fundamentally in relation to their anthropological foundations from a Catholic point of view. However, Allers’ thought has received rather limited attention from historians of psychiatry. The present study focuses on his conception of neurosis as a metaphysical conflict from a Neoscholastic point of view: the relationship between neurosis and character; his conception of neurosis as a metaphysical conflict; and his ideas about inner transformation (metanoia) as a main therapeutic goal in the case of neurosis and its relationship with sanctity as health and as a path to recovery.

APA, Harvard, Vancouver, ISO, and other styles

46

Zheng, Feng, Yinglong Duan, Jingle Li, Lin Lai, Zhuqing Zhong, Manhui Hu, and Siqing Ding. "Somatic symptoms and their association with anxiety and depression in Chinese patients with cardiac neurosis." Journal of International Medical Research 47, no. 10 (August 26, 2019): 4920–28. http://dx.doi.org/10.1177/0300060519869711.

Full text

Abstract:

Objective We sought to investigate somatic symptoms detected by the Somatic Self-rating Scale and to evaluate whether they were associated with the psychological symptoms of anxiety and depression in patients with cardiac neurosis. Methods A total of 180 patients with cardiac neurosis at the Third Xiangya Hospital, Changsha, China, were surveyed from January 2017 to July 2018. Participants completed a general information questionnaire, the Somatic Self-rating Scale, the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder Scale-7. Results The mean (±standard deviation) somatic symptom score in patients with cardiac neurosis was 40.83 ± 7.12. The most severe symptoms were cardiovascular symptoms, fatigue and muscle soreness. A total of 90 patients (46.4%) had anxiety and 80 (50.0%) had depression. Multiple stepwise regression analysis showed that somatic symptoms in patients with cardiac neurosis were associated with both anxiety and depression. Conclusion Somatic symptoms in patients with cardiac neurosis were associated with both anxiety and depression. Therefore, it is important to provide effective emotional interventions to promote patient rehabilitation.

APA, Harvard, Vancouver, ISO, and other styles

47

Gwiaździński, Paweł. "Czy neuroza jest językiem prywatnym?" Prace Naukowe Akademii im. Jana Długosza w Częstochowie. Filozofia 13 (2016): 123–31. http://dx.doi.org/10.16926/fil.2016.13.09.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Riddington Young, Annie. "Freud’s friend Fliess." Journal of Laryngology & Otology 116, no. 12 (December 2002): 992–95. http://dx.doi.org/10.1258/002221502761698702.

Full text

Abstract:

Fliess, an ENT surgeon, was Freud’s closest friend and confidant. They both believed that sexual problems were the chief cause of neurosis. Fliess postulated that eflex nasal neurosis was based on the important physiological connection between the nose and the genitals. He described specific genital spots located on the nasal inferior turbinate. Fliess’ second preoccupation was with vital periodicities. He believed that the symptoms of his reflex nasal neurosis followed regular 28-day cycles as does menstruation. He further proposed a male 23-day menstrual cycle, that he centred specifically on the nasal turbinate. Clearly, Fliess’ fanciful theories of neurosis based on the turbinates have never held any scientific validity and are presented for their curiosity. This eccentric rhinolaryngologist, however,exerted a profound influence on Freud’s conception of human development, that is often undervalued.

APA, Harvard, Vancouver, ISO, and other styles

49

Ghorpade, V. A. P. "Reflex neurosis (NEAD)." Indian Journal of Psychiatry 50, no. 1 (2008): 71. http://dx.doi.org/10.4103/0019-5545.39767.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Cabaj, Robert P. "Homosexuality and Neurosis:." Journal of Homosexuality 15, no. 1-2 (May 21, 1988): 13–23. http://dx.doi.org/10.1300/j082v15n01_03.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!